Fusion Family Wealth’s Amgen AMGN Stock Holding History

Fusion Family Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41	Closed	-$6K	–	320
2016 Q4	$6K	Buy	+41	New	+$6.17K	﹤0.01%	286

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fusion Family Wealth's AMGN Position: Q1 2017 in Review

Fusion Family Wealth sold out of Amgen (AMGN) in Q1 2017, closing a stake of 41 shares — an estimated $6K sold.

Fusion Family Wealth first reported a position in AMGN in Q4 2016 and held it in 1 quarter. The position peaked at $6K in Q4 2016. 1,601 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

Fusion Family Wealth reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
Fusion Family Wealth sold 41 Amgen shares in Q1 2017, an estimated $6K.
Fusion Family Wealth first reported a position in Amgen in Q4 2016 and held it in 1 quarter.
Fusion Family Wealth's Amgen position peaked at $6K in Q4 2016.
1,601 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Fusion Family Wealth's 13F filing for Q1 2017, filed 8 May 2017.